Renovo, Shire Developing Anti-Scar Drug: "The resilience of alligator embryos could hold the clue to reducing scars in people after surgery.
A British company, Renovo Group PLC, is developing an experimental injectable drug designed to prevent or reduce scarring. The drug, Juvista, originated in experiments conducted by Renovo's founder a quarter century ago in animal embryos. Renovo and its partner, Shire PLC, believe Juvista has blockbuster potential if patient trials are successful and it receives regulatory approval."
No comments:
Post a Comment